Literature DB >> 23246990

Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts.

A J Yost, O O Shevchuk, R Gooch, S Gusscott, M J You, T A Ince, J C Aster, A P Weng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23246990      PMCID： PMC4704859          DOI： 10.1038/leu.2012.337

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

Authors:  Mari H Dallas; Barbara Varnum-Finney; Paul J Martin; Irwin D Bernstein
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

2.  Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity.

Authors:  B Gerby; F Armstrong; P B de la Grange; H Medyouf; J Calvo; E Verhoeyen; F L Cosset; I Bernstein; S Amselem; N Boissel; H Dombret; T Leblanc; A Baruchel; J Landman-Parker; P Ballerini; F Pflumio
Journal:  Leukemia       Date:  2009-11-19       Impact factor: 11.528

3.  Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance.

Authors:  Priscilla P L Chiu; Hong Jiang; John E Dick
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

4.  Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.

Authors:  Charlotte V Cox; Hannah M Martin; Pamela R Kearns; Paul Virgo; Roger S Evely; Allison Blair
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

5.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

6.  Characterization of murine hemopoietic-supportive (MS-1 and MS-5) and non-supportive (MS-K) cell lines.

Authors:  J Suzuki; J Fujita; S Taniguchi; K Sugimoto; K J Mori
Journal:  Leukemia       Date:  1992-05       Impact factor: 11.528

7.  Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

Authors:  M A Soos; C E Field; K Siddle
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

8.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

Authors:  Tan A Ince; Andrea L Richardson; George W Bell; Maki Saitoh; Samuel Godar; Antoine E Karnoub; James D Iglehart; Robert A Weinberg
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Authors:  Anthony H Goldstone; Susan M Richards; Hillard M Lazarus; Martin S Tallman; Georgina Buck; Adele K Fielding; Alan K Burnett; Raj Chopra; Peter H Wiernik; Letizia Foroni; Elisabeth Paietta; Mark R Litzow; David I Marks; Jill Durrant; Andrew McMillan; Ian M Franklin; Selina Luger; Niculae Ciobanu; Jacob M Rowe
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

10.  High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.

Authors:  Hind Medyouf; Samuel Gusscott; Hongfang Wang; Jen-Chieh Tseng; Carol Wai; Oksana Nemirovsky; Andreas Trumpp; Francoise Pflumio; Joan Carboni; Marco Gottardis; Michael Pollak; Andrew L Kung; Jon C Aster; Martin Holzenberger; Andrew P Weng
Journal:  J Exp Med       Date:  2011-08-01       Impact factor: 14.307
View more
  9 in total

1.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Li Pan; Richard W J Groen; Frederic Baleydier; Alex Kentsis; Jason Marineau; Ruta Grebliunaite; Elena Kozakewich; Casie Reed; Francoise Pflumio; Sandrine Poglio; Benjamin Uzan; Paul Clemons; Lynn VerPlank; Frank An; Jason Burbank; Stephanie Norton; Nicola Tolliday; Hanno Steen; Andrew P Weng; Huipin Yuan; James E Bradner; Constantine Mitsiades; A Thomas Look; Jon C Aster
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

2.  Finding ARIEL under the sea of T-ALL circuits.

Authors:  Mark Y Chiang
Journal:  Blood       Date:  2019-07-18       Impact factor: 22.113

3.  c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.

Authors:  Justine E Roderick; Jessica Tesell; Leonard D Shultz; Michael A Brehm; Dale L Greiner; Marian H Harris; Lewis B Silverman; Stephen E Sallan; Alejandro Gutierrez; A Thomas Look; Jun Qi; James E Bradner; Michelle A Kelliher
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

4.  Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.

Authors:  Tan A Ince; Aurea D Sousa; Michelle A Jones; J Chuck Harrell; Elin S Agoston; Marit Krohn; Laura M Selfors; Wenbin Liu; Ken Chen; Mao Yong; Peter Buchwald; Bin Wang; Katherine S Hale; Evan Cohick; Petra Sergent; Abigail Witt; Zhanna Kozhekbaeva; Sizhen Gao; Agoston T Agoston; Melissa A Merritt; Rosemary Foster; Bo R Rueda; Christopher P Crum; Joan S Brugge; Gordon B Mills
Journal:  Nat Commun       Date:  2015-06-17       Impact factor: 14.919

5.  IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.

Authors:  Samuel Gusscott; Catherine E Jenkins; Sonya H Lam; Vincenzo Giambra; Michael Pollak; Andrew P Weng
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

6.  SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival.

Authors:  Hexiu Su; Juncheng Hu; Liang Huang; Yang Yang; Morgan Thenoz; Anna Kuchmiy; Yufeng Hu; Peng Li; Hui Feng; Yu Zhou; Tom Taghon; Pieter Van Vlierberghe; Guoliang Qing; Zhichao Chen; Hudan Liu
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

7.  Synthetic modeling reveals HOXB genes are critical for the initiation and maintenance of human leukemia.

Authors:  Manabu Kusakabe; Ann Chong Sun; Kateryna Tyshchenko; Rachel Wong; Aastha Nanda; Claire Shanna; Samuel Gusscott; Elizabeth A Chavez; Alireza Lorzadeh; Alice Zhu; Ainsleigh Hill; Stacy Hung; Scott Brown; Artem Babaian; Xuehai Wang; Robert A Holt; Christian Steidl; Aly Karsan; R Keith Humphries; Connie J Eaves; Martin Hirst; Andrew P Weng
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

8.  Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.

Authors:  Benjamin Uzan; Sandrine Poglio; Bastien Gerby; Ching-Lien Wu; Julia Gross; Florence Armstrong; Julien Calvo; Xavier Cahu; Caroline Deswarte; Florent Dumont; Diana Passaro; Corinne Besnard-Guérin; Thierry Leblanc; André Baruchel; Judith Landman-Parker; Paola Ballerini; Véronique Baud; Jacques Ghysdael; Frédéric Baleydier; Francoise Porteu; Francoise Pflumio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

9.  Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.

Authors:  Birgit Knoechel; Ami Bhatt; Li Pan; Chandra S Pedamallu; Eric Severson; Alejandro Gutierrez; David M Dorfman; Frank C Kuo; Michael Kluk; Andrew L Kung; Patrick Zweidler-McKay; Matthew Meyerson; Stephen C Blacklow; Daniel J DeAngelo; Jon C Aster
Journal:  Cold Spring Harb Mol Case Stud       Date:  2015-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.